Kelly-Nemecek
Survivor: Breast Cancer
I am a Survivor
Diagnosed in 2015 with Stage IIIA ILC, ER/PR+, HER2- breast cancer. I had a bilateral mastectomy followed by four rounds of Taxotere/Cytoxan, then 33 radiation treatments. I am currently taking Letrozole, an aromatase inhibitor.
Diagnosed in 2015 with Stage IIIA ILC, ER/PR+, HER2- breast cancer. I had a bilateral mastectomy followed by four rounds of Taxotere/Cytoxan, then 33 radiation treatments. I am currently taking Letrozole, an aromatase inhibitor.
Treatment Information
Stage of Treatment
Finished treatment less than 5 years ago
Treatment Types:
Bilateral (Double) Mastectomy
Chemotherapy
Hormone Therapy
Radiation Therapy
Hospital:
N/A
Side Effect:
IHC Blog Posts (4)
Kelly-Nemecek has not created any journal entries yet.